Ivermectine Sandoz

Ivermectin, the active ingredient in Ivermectine Sandoz, is a macrocyclic lactone anthelmintic presented as an oral dosage form for oral use. It is employed to treat a range of parasitic infections such as onchocerciasis, strongyloidiasis, scabies and pediculosis in patients requiring prescription therapy.

GNH USA supplies Ivermectine Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ivermectin acts on a broad spectrum of parasitic organisms, interfering with their neuromuscular function. It is indicated for the following conditions: - Onchocerciasis: reduces microfilarial load and prevents disease progression. - Strongyloidiasis: eradicates intestinal larvae and prevents systemic dissemination. - Scabies: eliminates Sarcoptes mites, relieving skin lesions and itching. - Pediculosis: kills head lice and nits, controlling infestation. - Other helminth infections: treats various nematode infections where ivermectin is approved.

Ivermectin is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: loose stools occurring shortly after dosing. - Dizziness: transient light‑headedness. - Pruritus: skin itching unrelated to the treated condition.

Serious or Rare Side Effects: - Hypersensitivity reactions: rash, swelling, or anaphylaxis. - Neurological signs: seizures, ataxia, or altered consciousness. - Hepatotoxicity: elevated liver enzymes indicating liver stress.

Before initiating therapy, consider the following precautions: - Pregnancy: avoid use unless the potential benefit outweighs the risk, as safety data are limited. - Breastfeeding: consult a healthcare professional before use. - Liver impairment: dose adjustment may be required in patients with hepatic dysfunction. - Drug interactions: review concomitant medications for potential interactions. - Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Ivermectin may interact with several medicines, requiring careful management.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): may increase ivermectin plasma levels. - P-glycoprotein inhibitors (e.g., verapamil): can raise systemic exposure.

Moderate Interactions (Monitor Closely): - Anticoagulants (e.g., warfarin): monitor coagulation parameters. - CNS depressants (e.g., benzodiazepines): observe for enhanced sedation. - Other antiparasitics: assess for additive toxicity.